ResMed | RMD - Des Atouts





Des Atouts Changement Date
Ansell USD 3.33B 3.2M 2025-12
Artivion USD 1.07B 188.78M 2026-06
AtriCure USD 676.64M 32.66M 2026-06
Baxter International USD 19.79B 55M 2026-06
Cochlear AUD 2.79B 31.3M 2025-12
Cooper Companies USD 12.48B 58.1M 2026-03
CSL USD 37.9B 1.5B 2025-12
Dexcom USD 6.46B 178M 2026-06
Edwards Lifesciences USD 13.87B 545.9M 2026-06
Fisher Paykel Healthcare NZD 2.85B 222.3M 2026-06
Globus Medical USD 5.49B 48.7M 2026-06
Haemonetics USD 2.37B 30.52M 2026-06
Idexx Laboratories USD 3.44B 56.84M 2026-06
Inogen USD 307.01M 5.03M 2025-09
Insulet USD 3.17B 177.9M 2026-06
Integra LifeSciences USD 3.56B 14.24M 2026-06
Intuitive Surgical USD 20.88B 765.6M 2026-06
Medtronic USD 91.48B 139M 2025-12
Philips EUR 26.7B 565M 2026-06
Ramsay Health Care AUD 21.7B 777.8M 2025-12
ResMed USD 8.97B 181.66M 2026-06
Sigma Healthcare AUD 8.29B 6.91B 2025-12
Sonic Healthcare AUD 15.38B 550.57M 2024-12
Steris USD 10.74B 1.1M 2026-06
Teleflex USD 6.79B 3.78M 2026-06
Thermo Fisher Scientific USD 113.17B 107M 2026-06